Pre‐ and postjunctional β‐adrenoreceptors and hypertension
1988; Wiley; Volume: 8; Issue: 2 Linguagem: Inglês
10.1111/j.1474-8673.1988.tb00179.x
ISSN1365-2680
Autores Tópico(s)Heart Rate Variability and Autonomic Control
ResumoJournal of Autonomic PharmacologyVolume 8, Issue 2 p. 153-171 Pre- and postjunctional β-adrenoreceptors and hypertension K. R. Borkowski, Corresponding Author K. R. Borkowski Division of Clinical Pharmacology, The John. P. Robarts Research Institute, London, Ontario, CanadaDr. K. R. Borkowski, Division of Clinical Pharmacology, The John P. Robarts Research Institute, PO Box 5015, 100 Perth Drive, London, Ontario, Canada N6A 5K8.Search for more papers by this author K. R. Borkowski, Corresponding Author K. R. Borkowski Division of Clinical Pharmacology, The John. P. Robarts Research Institute, London, Ontario, CanadaDr. K. R. Borkowski, Division of Clinical Pharmacology, The John P. Robarts Research Institute, PO Box 5015, 100 Perth Drive, London, Ontario, Canada N6A 5K8.Search for more papers by this author First published: June 1988 https://doi.org/10.1111/j.1474-8673.1988.tb00179.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Adler-Graschinsky, E. and Langer, S. Z. (1975). Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feedback mechanism. Br. J. Pharmac. 53, 43–50. Agrawal, D. K. and Daniel, E. E. (1984). Increased density of (3H)yohimbine binding sites in spontaneously hypertensive rat mesenteric artery. J. Hypertens. 2, suppl. 3, 107–110. Ahlquist, R. P. (1948). A study of the adrenotropic receptors. Am. J. Physiol. 153, 586–600. Angus, J. A. and Korner, P. I. (1980). Evidence against presynaptic alpha-adrenoceptor modulation of cardiac sympathetic transmission. Nature, 286, 288–291. Asano, M., Aoki, K. and Matsuda, T. (1982). Reduced beta adrenoceptor interactions of norepinephrine enhance contraction in the femoral artery from spontaneously hypertensive rats. J. Pharmac. exp. Ther. 233, 207–214. Barrett, A. M. (1978). Release modulating adrenoceptors. In: Recent Advances in the Pharmacology of Adrenoceptors, pp. 169–171. Eds E. Szabadi, C. M. Bradshaw and P. Bevan. Elsevier/North-Holland Biomedical Press, Amsterdam . Berecek, K. H., Schwertschlag, M. and Gross, F. (1980). Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am. J. Physiol. 238, H287–293. Bertel, O., Buhler, F. R., Kiowski, W. and Lutold, B. E. (1980). Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension, 2, 130–138. Berthelson, S. and Pettinger, W. A. (1977). A functional basis for classification of alpha-adrenergic receptors. Life Sci. 21, 596–606. Bevan, J. A. (1984). 'The gamma-connection': are we ready to throw out the alpha-adrenoceptor in sympathetic vasoconstriction Trends in Pharmac. Sci. 5, 53–55. Blakeley, A. G. H., Cunnane, T. C. and Petersen, S. A. (198la). An electropharmacological analysis of the effects of some drugs on neuromuscular transmission in the vas deferens of the guinea-pig. J. auton. Pharmac. 1, 367–375. Blakeley, A. G. H., Cunnane, T. C. and Petersen, S. A. (1981b). The packeted release of sympathin from single release sites in the rodent vas deferens. Is release subject to feedback control? In: Chemical Neurotransmission: 75 Years, pp. 201–210. Eds L. Stjarne, P. Hedqvist, H. Lagercrantz and A. Wenmalm. Academic Press, London . Blakeley, A. G. H., Cunnane, T. C. and Petersen, S. A. (1982). Local regulation of transmitter release from rodent sympathetic nerve terminals J. Physiol. 325, 93–109. Borkowski, K. R. and Kelly, E. (1986). The effect of adrenal demedullation on cardiovascular responses to environmental stimulation in conscious rats. Br. J. Pharmac. 88, 943–945. Borkowski, K. R. and Porter, M. (1983). Betaadrenoreceptor-mediated modulation of vasoconstriction in isolated perfused rat mesenteric arteries. J. auton. Pharmac. 3, 275–279. Borkowski, K. R. and Porter, M. (1984). An altered Beta-adrenoreceptor-mediated modulation of noradrenaline-induced vasoconstriction in spontaneously hypertensive rat mesenteric arteries. J. auton. Pharmac. 4, 27–31. Borkowski, K. R. and Porter, M. (1985). Reduced Beta-adrenoreceptor-mediated vasodilatation in spontaneously hypertensive rats (SHR). Br. J. Pharmac. 84, 158P. Borkowski, K. R. and Quinn, P. (1984a). Facilitation by Beta-adrenoreceptors of stimulation-induced vasoconstriction in pithed spontaneously hypertensive rats. J. auton. Pharmac. 4, 127–132. Borkowski, K. R. and Quinn, P. (1984b). Beta2-adrenoreceptors mediate adrenaline's facilitation of neurogenic vasoconstriction. Eur. J. Pharmac. 103, 339–342. Borkowski, K. R. and Quinn, P. (1984c). Adrenaline and the development of genetic hypertension. J. Hypertens. 2, suppl. 3, 81–83. Borkowski, K. R. and Quinn, P. (1985). Adrenaline and the development of spontaneous hypertension in rats. J. Auton. Pharmacol. 5, 89–100. Broadley, K. J. (1982). Cardiac adrenoreceptors. J. auton. Pharmac. 2, 119–145. Brown, M. J. and Macquin, I. (1981). Is adrenaline the cause of essential hypertension Lancet, ii, 1079–1082. Celuch, S. M., Dubocovich, M. L. and Langer, S. Z. (1978). Stimulation of presynaptic β-adrenoreceptors enhances 3H-noradrenaline release during nerve stimulation in the perfused cat spleen. Br. J. Pharmac. 63, 97–108. Chan, C. and Kalsner, S. (1979). An examination of the negative feedback function of presynaptic adrenoceptors in a vascular tissue. Br. J. Pharmac. 67, 401–407. Cheng, J. B. and Shibata, S. (1981). Vascular relaxation in the spontaneously hypertensive rat. J. cardiovasc. Pharmac. 3, 1126–1140. Cohen, M. L. and Berkowitz, B. A. (1976). Decreased vascular relaxation in hypertension. J. Pharmac. exp. Ther. 196, 396–406. Cohen, M. L. and Wiley, K. S. (1977). Specific enhancement of norepinephrine-induced contraction in rat veins after beta adrenergic antagonists. J. Pharmac. exp. Ther. 201, 406–416. Conway, J. (1984). Hemodynamic aspects of essential hypertension in humans. Physiol. Rev. 64, 617–660. Couture, R. and Regoli, D. (1980). Vascular reactivity to angiotensin and noradrenaline in spontaneously and renal hypertensive rats. Clin. exp. Hypertens. 2, 45–63. Cubeddu, L. X. and Weiner, N. (1975). Nerve stimulation-mediated overflow of norepinephrine and dopamine-β-hydroxylase. III. Effects of norepinephrine depletion on the alpha-presynaptic regulation of release. J. Pharmac. exp. Ther. 192, 1–14. Dahlof, C. (1981). Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission. Acta Physiol. Scand. (suppl.) 500, 1–147. Dahlof, C., Ablad, B., Borg, K. O., Ek, L. and Waldeck, B. (1975). Pre-junctional inhibition of adrenergic nervous vasomotor control due to β-receptor blockade. In: Chemical Tools in Catecholamine Research, Vol. 2, pp. 201–210. Eds O. Almgren, A. Carlsson and J. Engel. North-Holland, Amsterdam . Dale, H. H. (1906). On some physiological actions of ergot. J. Physiol. 34, 163–206. DeChamplain, J., Cousineau, D., Van Ameringen, M. R., Marc Aurele, J. and Yamaguchi, N. (1977). The role of the sympathetic system in experimental and human hypertension. Postgrad. Med. J. 53, suppl. 3, 15–30. DeChamplain, J., Farley, L., Cousineau, D. and Van Ameringen, M. R. (1974). Circulating catecholamine levels in human and experimental hypertension. Circ. Res. 38, 109–114. Dismukes, K., DeBoer, A. A. and Mulder, A. H. (1977). On the mechanism of alphareceptor mediated modulation of 3H-noradrenaline release from slices of rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmac. 299, 115–122. Docherty, J. R. (1986). Prejunctional inhibitory actions of alpha1-adrenoreceptor agonists in the rat. Br. J. Pharmac. 89, 842P. Dubocovich, M. L. and Langer, S. Z. (1974). Negative feedback regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking pre- and post-synaptic adrenergic receptors. J. Physiol. 237, 505–519. Dubocovich, M. L., Langer, S. Z. and Pelayo, F. (1978). Effect of cyclic nucleotides on (3H)-neurotransmitter release induced by potassium stimulation in the rat pineal gland. Br. J. Pharmac. 62, 383P–384P. Eliasson, K., Hjemdahl, P. and Kahan, T. (1983). Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension. J. Hypertens. 1, 131–140. Endo, T., Starke, K., Bangerter, A. and Taube, H. D. (1977). Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmac. 296, 229–247. Esler, M., Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G. and Korner, P. (1981). Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension, 3, 149–156. Farnebo, L. O. and Hamberger, B. (1974). Influence of α- and β-adrenoreceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J. Pharm. Pharmac. 26, 644–646. Field, F. P., Janis, R. A. and Triggle, D. J. (1972). Aortic reactivity of rats with genetic and experimental renal hypertension. Can. J. Physiol. Pharmac. 50, 1072–1079. Floras, J. S., Aylward, P. E., Mark, A. L. and Abboud, F. M. (1985). Contrasting effects of epinephrine and isoproterenol on neurogenic vasoconstriction: evidence for a cotransmitter and facilitatory role for epinephrine in man. Abs. AHA Council for High Blood Pressure Research 39th Annual Fall Conference, Cleveland, Ohio, 49. Folkow, B. (1982). Physiological aspects of primary hypertension. Physiol. Rev. 62, 347–504. Folkow, B., DiBona, G. F., Hjemdahl, P., Thoren, P. H. and Wallin, B. G. (1983). Measurements of plasma norepinephrine concentration in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension, 5, 399–403. Folkow, B., Hallback, M., Lundgren, Y. and Weiss, L. (1980). Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol. Scand. 80, 93–106. Franco-Morselli, R., Elghozi, J. L., Joly, E., DiGuilio, S. and Meyer, P. (1977). Increased plasma adrenaline concentrations in benign essential hypertension. Br. Med. J. 2, 1251–1254. Furchgott, R. F. (1967). The pharmacological differentiation of adrenergic receptors. Ann. N. Y. Acad. Sci. 139, 553–570. Gillespie, J. S. (1980). Presynaptic receptors in the autonomic nervous system. In: Handbook of Experimental Pharmacology: Adrenergic Activators and Inhibitors, Vol. 54, pp. 353–425. ed. L. Szekeres. Springer-Verlag, Berlin . Goldstein, D. D. (1981). Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension, 3, 48–52. Goldstein, D. D. (1983). Plasma catecholamines and essential hypertension; An analytical review. Hypertension, 5, 86–99. Granata, A. R., Enero, M. A., Krieger, E. M. and Langer, S. Z. (1983). Norepinephrine release and vascular response elicited by nerve stimulation in rats with chronic neurogenic hypertension. J. Pharmac. exp. Ther. 227, 187–193. Grant, J. A. and Scrutton, M. G. (1979). Novel alpha2-adrenoceptors primarily responsible for inducing human platelet aggregation. Nature, 277, 659–661. Green, G. J., Wilson, M. and Jates, M. S. (1979). The mechanism of clonidine-induced reduction in peripheral parasympathetic sub-maxillary salivation. Eur. J. Pharmac. 56, 331–345. Harms, H. H. (1976). Cardioselectivity of beta-adrenoreceptor blocking agents: in vitro studies with human and guinea-pig preparations. In: Beta-adrenoreceptor Blocking Agents, pp. 311–315. eds. P. R. Saxena and R. P. Forsyth, Elsevier/North Holland Biomedical Press, Amsterdam . Hedqvist, P. and Moawad, A. (1975). Presynaptic α- and β-adrenoreceptor mediated control of noradrenaline release in human oviduct. Acta Physiol. Scand. 95, 494–496. Hirst, G. D. S. and Neild, T. O. (1980). Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle. Nature, 283, 767–768. Hirst, G. D. S. and Neild, T. O. (1981). Localization of specialized noradrenaline receptors at neuromuscular junctions on arterioles of the guinea-pig. J. Physiol. 313, 343–350. Hoffman, B. B., DeLean, A., Wood, C. L., Schocken, D. D. and Lefkowitz, R. J. (1979). Alpha-adrenergic receptor subtypes; quantitative assessment by ligand binding. Life Sci. 24, 1739–1746. Holman, M. E. and Suprenant, A. (1980). An electrophysiological analysis of the effects of noradrenaline and alpha-receptor antagonists on neuromuscular transmission in mammalian muscular arteries. Br. J. Pharmac. 71, 651–661. Hurwitz, M. L. and Rosendorff, C. (1985). Cardiovascular adrenoceptor number and function in experimental hypertension in baboon. J. cardiovasc. Pharmac. 7, suppl. 6, S172–S177. Imms, F. J., Neame, R. L. B. and Powis, D. A. (1974). The effects of beta-adrenergic blockade upon the cardiovascular responses of the rat to noradrenaline infusions. J. Physiol. 241, 47P–49P. Ito, Y., Kitamura, K. and Kuriyama, H. (1979). Effects of acetylcholine and catecholamines on the smooth muscle cell of the porcine coronary artery. J. Physiol. 294, 595–611. Iversen, L. L. (1975). Uptake mechanisms for biogenic amines. In: Handbook of Psycho-pharmacology, Vol. 3, pp. 381–442. Eds L. L. Iversen, S. D. Iversen and S. H. Snyder. Plenum Press, New York . Kalsner, S. (1979). Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br. J. Pharmac. 66, 343–349. Kalsner, S. (1980). Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation induced efflux of (3H)noradrenaline in vas deferens. J. Pharmac. exp. Ther. 212, 232–239. Kalsner, S. and Chan, C. (1979). Adrenergic antagonists and the presynaptic receptor hypothesis in vascular tissue. J. Pharmac. exp. Ther. 211, 257–264. Kalsner, S. and Quillan, M. (1984). A hypothesis to explain the presynaptic effects of adrenoceptor antagonists. Br. J. Pharmac. 82, 515–522. Kirpekar, S. M., Furchgott, R. F., Wakade, A. R. and Prat, J. C. (1973). Inhibition by sympathomimetic amines of the release of norepinephrine evoked by nerve stimulation in the cat spleen. J. Pharmac. exp. Ther. 187, 529–538. Kjeldsen, S. E., Flaaten, B., Eide, I., Helgeland, A. and Leren, P. (1981). Increased peripheral release of noradrenalin and uptake of adrenalin in essential hypertension Clin. Sci. 61, suppl. 215–217. Kobayashi, H., Wada, A., Izumi, F., Magnoni, M. S. and Trabucchi, M. (1985). Alphaadrenergic receptors in cerebral microvessels of normotensive and spontaneously hypertensive rats. Circ. Res. 56, 402–409. Lais, T. and Brody, M. J. (1978). Vasoconstrictor hyperresponsiveness: an early pathogenic mechanism in the spontaneously hypertensive rat. Eur. J. Pharmac. 47, 177–189. Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P. and Brown, T. G. (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature, 214, 597–598. Langer, S. Z. (1974). Presynaptic regulation of catecholamine release. Biochem. Pharmac. 23, 1793–1800. Langer, S. Z. (1977). Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol. 60, 481–497. Langer, S. Z. (1981). Presynaptic regulation of the release of catecholamines. Pharmac. Rev. 32, 337–362. Langer, S. Z. and Dubocovich, M. L. (1978). Physiological and pharmacological relevance of presynaptic beta-adrenoceptors in modulating transmitter release. In: Recent Advances in the Pharmacology of Adrenoceptors, pp. 181–189. Eds E. Szabadi, C. M. Bradshaw and P. Beven. Elsevier/North-Holland Biomedical Press, Amsterdam . Langer, S. Z., Dubocovich, M. L. and Celuch, S. M. (1975a). Prejunctional regulatory mechanisms for noradrenaline release elicited by nerve stimulation. In: Chemical Tools in Catecholamine Research, Vol. 2, pp. 183–191. Eds O. Almgren, A. Carlsson and J. Engel. North-Holland, Amsterdam . Langer, S. Z., Enero, M. A., Adler-Graschinsky, E., Dubocovich, M. L. and Celuch, S. M. (1975b). Presynaptic regulatory mechanisms for noradrenaline release by nerve stimulation. In: Central Action of Drugs in Blood Pressure Regulation, pp. 133–150. Eds D. S. Davies and J. L. Reid. Pitman, Tunbridge Wells . Lee, R. M. K. W., Forrest, J. B., Garfield, R. E. and Daniel, E. E. (1983). Ultrastructural changes in mesenteric arteries from spontaneously hypertensive rats. Blood Vessels, 20, 72–91. Lee, R. M. K. W., Garfield, R. E., Forrest, J. B. and Daniel, E. E. (1984) Smooth muscle cell herniation in the contracted arterial wall of spontaneously hypertensive and normotensive rats. Acta Anat. 119, 65–72. Limas, C. J. and Limas, C. (1978). Reduced number of beta-adrenergic receptors in the myocardium. Biochem. Biophys. Res. Comm. 83, 710–714. Limas, C. J. and Limas, C. (1979). Decreased number of beta-adrenergic receptors in hypertensive vessels. Biochim. et Biophys. Act. 582, 533–536. Majewski, H. (1983). Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J. auton. Pharmac. 3, 47–60. Majewski, H., Tung, L-H. and Rand, M. J. (1981). Adrenaline-induced hypertension in rats. J. cardiovasc. Pharmac. 3, 179–185. Majewski, H., Tung, L-H. and Rand, M. J. (1982). Adrenaline activation of prejunctional beta-adrenoceptors and hypertension. J. cardiovasc. Pharmac. 4, 99–106. Malik, K. U. and Nasjletti, A. (1976). Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ. Res. 38, 26–30. Minneman, K. P., Pittman, R. N. and Molinoff, P. B. (1981). Beta-adrenergic receptor subtypes: properties, distribution and regulation. Ann. Rev. Neurosci. 4, 419–461. Mueller, H. S. and Ayres, S. M. (1980). Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J. Clin. Invest. 65, 338–346. Mulvany, M. J. (1983). Do resistance vessel abnormalities contribute to the elevated blood pressure of spontaneously hypertensive rats? A review of some of the evidence. Blood Vessels, 20, 1–22. Mulvany, M. J., Aalkjaer, C. and Christensen, J. (1980). Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension, 2, 664–671. Nahorski, S. R. and Barnett, D. B. (1982). Biochemical assessment of adrenoceptor function and regulation: new directions and clinical relevance. Clin. Sci. 63, 97–105. Nakamaru, M., Jackson, E. K. and Inagami, T. (1986a). β-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am. J. Physiol. 250, H144–H148. Nakamaru, M., Jackson, E. K. and Inagami, T. (1986b). Role of vascular angiotensin II released by β-adrenergic stimulation in rats. J. cardiovasc. Pharmac. 8, suppl. 10, 1–5. Nelson, G. I. C., Hussain, M., Forsyth, D., Wilson, J., Silke, B. and Taylor, S. H. (1984). Haemodynamic effects of selective alpha1-blockade (trimazosin) in essential hypertension. J. Cardiovasc. Pharmacol. 6, 176–181. Pickering, G. W. (1968). High Blood Pressure. J. and A. Churchill Press, London . Quinn, P., Borkowski, K. R. and Collis, M. G. (1985). Epinephrine enhances neurogenic vasoconstriction in the rat perfused kidney. Hypertension, 7, 47–52. Shibata, S., Kurahashi, K. and Kuchi, M. (1973). A possible aetiology of contractility impairment of vascular smooth muscle from spontaneously hypertensive rats. J. Pharmac. exp. Ther. 185, 406–417. Sivertsson, R. and Olander, R. (1968). Aspects of the nature of the increased vascular resistance and increased 'reactivity' to noradrenaline in hypertensive subjects. Life Sci. 7, 1291–1297. Spector, S., Fleisch, J. H., Maling, H. M. and Brodie, B. B. (1969). Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science, 166, 1300–1301. Starke, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochern. Pharmac. 77, 1–124. Starke, K. (1981). Presynaptic receptors. Ann. Rev. Pharmac. Toxicol. 21, 7–30. Starke, K. and Altmann, K. P. (1973). Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional alpha-receptors. Neuropharmacology, 12, 339–347. Starke, K., Endo, T. and Taube, H. D. (1975a). Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmac. 291, 55–78. Starke, K., Endo, T. and Taube, H. D. (1975b). Pre- and postsynaptic components in effects of drugs with alpha-adrenoceptor affinity. Nature, 254, 440–441. Starke, K., Endo, T., Taube, H. D. and Borowski, E. (1975c). Presynaptic receptor systems on noradrenergic nerves. In: Chemical Tools in Catecholamine Research, Vol. 2, pp. 193–200. Eds O. Almgren, A. Carlsson and J. Engel. North-Holland, Amsterdam . Starke, K. and Montel, H. (1974). Influence of drugs with affinity for alpha-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperazinium. Eur. J. Pharmac. 27, 273–280. Starke, K. and Schumann, H. J. (1972). Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation. Eur. J. Pharmac. 18, 27–30. Stevens, M. J., Rittinghausen, R. E., Medcalf, R. F. and Moulds, R. F. W. (1982). Prejunctional beta-adrenoceptors in human digital arteries. Eur. J. Pharmac. 83, 263–270. Stjarne, L. (1973). Frequency dependence of dual negative feedback control of secretion of sympathetic neurotransmitter in guinea-pig vas deferens. Br. J. Pharmac. 49, 358–360. Stjarne, L. and Brundin, J. (1975). Dual adrenoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by beta-receptors and inhibition by alpha-receptors. Acta Physiol. Scand. 94, 139–141. Stjarne, L. and Brundin, J. (1976a). Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol. Scand. 97, 88–93. Stjarne, L. and Brundin, J. (1976b). Additive stimulating effects of inhibitor of prostaglandin synthesis and of beta-adrenoceptor agonist on sympathetic neuroeffector function in human omental blood vessels. Acta Physiol. Scand. 97, 267–269. Stjarne, L. and Gripe, K. (1973). Prostaglandin-dependent and -independent feedback control of noradrenaline secretion in vasoconstrictor nerves of normotensive human subjects. A preliminary report. Naunyn-Schmiedeberg's Arch. Pharmac. 280, 441–446. Story, D. F., Standford-Starr, C. A. and Rand, M. J. (1985). Evidence for the involvement of alpha1-adrenoceptors in negative feedback regulation of noradrenergic transmitter release in rat atria. Clin. Sci. 68, Suppl. 10, 111 s–115s. Swamy, V. C. and Triggle, D. J. (1980). The reactivity of iliac vascular strips from spontaneously hypertensive and normotensive rats. Blood Vessels, 7, 246–256. Triggle, C. R. and Laher, I. (1985). A review of changes in vascular smooth muscle functions in hypertension: isolated tissue versus in vivo studies. Can. J. Physiol. Pharmac. 63, 355–365. Tung, L-H., Rand, M. J. and Majewski, H. (1981). Adrenaline-induced hypertension in rats. Clin. Sci. 61, suppl. 7, 191s–193s. Van Zwieten, P. A., Timmermans, P. B. M. W. M. and Van Brummelen, P. (1984). Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment. Am. J. Med. 77, 17–25. Vincent, J. H., Boomsma, F., Man In't Veld A. J. and Schalekamp, M. A. D. H. (1983). Beta-receptor stimulation by adrenaline elevates plasma noradrenaline and enhances the pressor responses to cold exposure and isometric exercise. J. Hypertens. 1, 74–76. Warnock, P. and Doherty, J. R. (1986). Further investigation of the sites of vascular alpha1 and alpha2 adrenoceptors in the anaesthetized spontaneously hypertensive rat. J. cardiovasc. Pharmac. 8, 67–70. Weinstock, M., Thoa, N. B. and Kopin, I. J. (1978). Beta-adrenoceptors modulate noradrenaline release from axonal sprouts in cultured rat superior cervical ganglia. Eur. J. Pharmac. 47, 297–302. Westfall, T. C. (1977). Local regulation of adrenergic neurotransmission. Physiol. Rev. 57, 659–728. Westfall, T. C. and Meldrum, M. J. (1985). Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Ann. Rev. Pharmac. Toxicol. 25, 621–641. Westfall, T. C., Peach, M. J. and Tittermary, V. (1979). Enhancement of the electrically induced release of norepinephrine from the rat portal vein: Mediation by β2-adrenoceptors. Eur. J. Pharmac. 58, 67–74. Whall, C. W., Myers, M. M. and Halpern, W. (1980). Norepinephrine sensitivity, tension development and neuronal uptake in resistance arteries from spontaneously hypertensive and normotensive rats. Blood Vessels, 17, 1–15. Wickberg, J. E. S. (1979). The pharmacological classification of adrenergic alpha1-receptors and their mechanism of action. Acta Physiol. Scand. (Suppl.) 468, 1–99. Woodcock, E. A. and Johnston, C. I. (1980). Changes in tissue alpha and beta adrenergic receptors in renal hypertension in rat. Hypertension, 2, 156–161. Yamaguchi, N., DeChamplain, J. and Nadeau, R. A. (1977). Regulation of norepinephrine release from cardiac sympathetic fibres in the dog by presynaptic alpha and beta receptors. Circ. Res. 41, 108–117. Zabludowski, J., Clark, S., Ball, S. G., Brown, A. J., Inglis, G. C., Lever, A. F. and Murray, G. (1984). Pressor effects of brief and prolonged infusions of epinephrine in the conscious rat. Am. J. Physiol. 246, H683–689. Citing Literature Volume8, Issue2June 1988Pages 153-171 ReferencesRelatedInformation
Referência(s)